IHC and ISH results, indicating number of positive cases
| Marker . | Positive cases (%) . |
|---|---|
| PTEN | 258/258 (100) |
| Bax | 259/266 (97.4) |
| Cyclin A | 262/271 (96.7) |
| Cyclin B1 | 239/257 (93) |
| Cyclin E | 231/257 (89.9) |
| Survivin | 234/262 (89.3) |
| STAT1 | 236/267 (88.4) |
| CDK1 | 269/264 (86.7) |
| SKP2 | 226/268 (84.3) |
| CDK2 | 223/265 (83.8) |
| P21 | 218/270 (80.7) |
| TUNEL | 169/210 (80.5) |
| P65/Re1A | 196/257 (76.3) |
| P16 | 189/259 (73) |
| Hdm2 | 171/244 (70.1) |
| STAT3 | 145/261 (55.6) |
| M1B1 | 121/265 (45.7) |
| Rb | 102/262 (38.9) |
| CyclinD3 | 103/267 (38.6) |
| EBER | 98/256 (38.3) |
| LMP | 96/252 (38.1) |
| Bcl2 | 61/264 (23.1) |
| P27 | 59/256 (23.0) |
| CDK6 | 54/262 (20.6) |
| Bcl-XL | 50/260 (19.2) |
| P53 | 41/265 (15.5) |
| Bcl6 | 24/254 (9.4) |
| Mcl1 | 18/263 (6.8) |
| Cyclin D1 | 14/270 (5.2) |
| Marker . | Positive cases (%) . |
|---|---|
| PTEN | 258/258 (100) |
| Bax | 259/266 (97.4) |
| Cyclin A | 262/271 (96.7) |
| Cyclin B1 | 239/257 (93) |
| Cyclin E | 231/257 (89.9) |
| Survivin | 234/262 (89.3) |
| STAT1 | 236/267 (88.4) |
| CDK1 | 269/264 (86.7) |
| SKP2 | 226/268 (84.3) |
| CDK2 | 223/265 (83.8) |
| P21 | 218/270 (80.7) |
| TUNEL | 169/210 (80.5) |
| P65/Re1A | 196/257 (76.3) |
| P16 | 189/259 (73) |
| Hdm2 | 171/244 (70.1) |
| STAT3 | 145/261 (55.6) |
| M1B1 | 121/265 (45.7) |
| Rb | 102/262 (38.9) |
| CyclinD3 | 103/267 (38.6) |
| EBER | 98/256 (38.3) |
| LMP | 96/252 (38.1) |
| Bcl2 | 61/264 (23.1) |
| P27 | 59/256 (23.0) |
| CDK6 | 54/262 (20.6) |
| Bcl-XL | 50/260 (19.2) |
| P53 | 41/265 (15.5) |
| Bcl6 | 24/254 (9.4) |
| Mcl1 | 18/263 (6.8) |
| Cyclin D1 | 14/270 (5.2) |
The different markers are ordered by the percentage of positive cases in the series (additional unreviewed information will be available on our website athttp://bioinfo.cnio.es/data/Hodgkin2003/).